Gli altri portali
Notizie a Confronto
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
COSRX Spring Deal Days Sale: Save Much on TikTok's Favorite Skincare Products at…
Advanced Snail 96 Mucin Power Essence Advanced Snail 96 Mucin Power Essence The TikTok viral COSRXAdvanced Snail 96 Mucin Power Essenceis formulated with filtered snail mucin to protect the skin barrier from losing moisture. Skincare influencers and Amazon reviewers rave about the product for revitalizing and hydrating the skin without irritation. One shopper calls it "the VIP ticket to hydration town," since it will "keep your skin plump and moist, the perfect combination for...
PR Newswire
20/03/2024
Results from Mont Blanc Phase 3 Trial of Nicox's NCX 470 in Glaucoma Published…
Press Release Results from Mont Blanc Phase 3 Trial of Nicox's NCX 470 in Glaucoma Published in the American Journal of OphthalmologyFirst publication of the data from the Mont Blanc Phase 3 trial in a peer-reviewed journalAuthors conclude: "NCX 470 could become an important first-line therapy for IOP reduction in glaucoma."Topline results from second Phase 3 trial of NCX 470, Denali, expected in H2 2025March 20, 2024 – release at 7:30 am CET Sophia Antipolis, France Nicox...
Nasdaq GlobeNewswire
20/03/2024
BioSenic presents successful preclinical data on its ATO medication for…
PRESS RELEASEPreclinical data in a transgenic mouse model shows beneficial effects on various clinical symptoms analogous to those observed in human systemic sclerosis.Findings may further support future clinical program. Mont-Saint-Guibert, Belgium, 20 March 2024, 7.00am CET –BioSenic(Euronext Brussels and Paris: BIOS),the clinical-stage company specializing in serious autoimmune and inflammatory diseases and cell therapy, presented the latest data on arsenic trioxide...
Nasdaq GlobeNewswire
20/03/2024
US FDA approves Idorsia's once-daily TRYVIO (aprocitentan) – the first and only…
Ad hoc announcement pursuant to Art. 53 LR TRYVIO™ (aprocitentan) is indicated for the treatment of hypertension in combination with other antihypertensive drugs, to lower blood pressure in adult patients who are not adequately controlled on other drugs.TRYVIO is the first oral anti-hypertensive therapy which works via a new therapeutic pathway to be approved in almost 40 years.Idorsia plans to make TRYVIO available to the millions of patients in the US who are not controlled on other...
Nasdaq GlobeNewswire
20/03/2024
Valneva Reports Full Year 2023 Results and Provides Business Updates and Outlook
Total revenues of €153.7 million, including product sales of €144.6 millionProduct sales surpassed pre-pandemic (2019) sales by 12% and 2022 sales by 26%Excluding COVID-19 vaccine sales, product sales grew by 63% compared to 2022Cash position of €126.1 million at year-end 2023 enhanced by €95 million from sale of Priority Review Voucher (PRV) 1 Extended the interest-only period of existing debt financing agreement to January 2026 significantly extending cash runway 2 ...
Nasdaq GlobeNewswire
20/03/2024
Robooter Showcases All Terrain Electric Wheelchair E60 Series at Naidex 2024 and…
E60 series is the first of its kind,smart,off-road power wheelchair launched by ROBOOTER. It delivers high endurance and fast driving speed with the perfect blend of design and function. E60 series is the first of its kind,smart,off-road power wheelchair launched by ROBOOTER. It delivers high endurance and fast driving speed with the perfect blend of design and function. The E60 and E60-A models are equipped with 10-inch omnidirectional wheels, while the E60Pro and E60 Pro-A feature larger...
PR Newswire
20/03/2024
Endo Announces Confirmation of Plan of Reorganization
Blaise Coleman, Endo's President and Chief Executive Officer, said, "We look forward to emerging as Endo, Inc., a stronger company poised for sustained growth. We are grateful for the collaboration and support from our many stakeholders throughout this process. I also want to express my gratitude to the entire Endo team for their continued focus on delivering quality, life-enhancing therapies, and serving our customers and patients throughout this process." Blaise Coleman, Endo's…
PR Newswire
19/03/2024
Nyxoah Announces DREAM U.S. Pivotal Study Meets Primary Endpoints
Nyxoah Announces DREAM U.S. Pivotal Study Meets Primary EndpointsReports an Apnea-Hypopnea Index (AHI) responder rate of 63.5% on an intent to treat (ITT) basis (p=0.002) Reports an Oxygen Desaturation Index (ODI) responder rate of 71.3% on an intent to treat (ITT) basis (p<0.001) Median 12-month AHI reduction of 70.8%Mont-Saint-Guibert, Belgium – March 19, 2024, 9:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical...
Nasdaq GlobeNewswire
19/03/2024
CARBOGEN AMCIS announces successful ANVISA audit of its facility in China
Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, announces the successful completion of its first Brazilian Regulatory Authority Agency (ANVISA) routine inspection of its facility in Shanghai.Between 6-10th November 2023, a five-day inspection was undertaken, which concluded successfully with no critical and no major observations raised. A Good Manufacturing Practice (GMP) certificate has been granted...
Nasdaq GlobeNewswire
19/03/2024
Virbac: Public Release of the Year-End Consolidated Accounts at 31 December 2023
Public release of Virbac Consolidated Accounts at 31 December 2023.The Group released its 2023 Consolidated Accounts. The document is available on the corporate website, at corporate.virbac.com, under “Investors”, “Financial Reports”. Attachment Public release of Virbac Consolidated Accounts 12.2023
Nasdaq GlobeNewswire
19/03/2024
Disclosure notification from Mawer Investment Management Ltd.
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 19 March 2024 – 6PM CET Disclosure notification from Mawer Investment Management Ltd. On 18 March 2024, Fagron received a notification pursuant to the Belgian law of 2 May 2007 regarding the disclosure of major shareholdings in listed companies from Mawer Investment Management Ltd. that its shareholding crossed the 5% disclosure threshold as the result of the acquisition of voting securities or voting rights on 15 March...
Nasdaq GlobeNewswire
19/03/2024
VIRBAC: 2023 ANNUAL RESULTS
Revenue up 4.9%, enabling market share gains despite difficulties in 20232023 operating profitability 1at an all-time high of 23.2% of revenueUp 0.4 points compared to 2022 Strongmomentumexpected in 2024Expected revenue growth of 4% to 6% at constant exchange rates and scopeOperating profitability 1expected to rise by 0,5 point CONSOLIDATED FIGURES AS OF DECEMBER 31 in millions of € 20232022 restated 62023/2022 change...
Nasdaq GlobeNewswire
19/03/2024
Zealand Pharma major shareholder announcement: Polar Capital
Company announcement – No. 16 / 2024 Zealand Pharma major shareholder announcement: Polar CapitalCopenhagen, Denmark, 19 March 2024 – Zealand Pharma A/S (“Zealand”) (Nasdaq: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announces the receipt on 18 March 2024 of notification pursuant to Section 38 of the Danish Capital Markets Act from the following major shareholders:As...
Nasdaq GlobeNewswire
19/03/2024
Transactions in Zealand Pharma shares and/or related securities by persons…
Company announcement – No. 15 / 2024 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, March 19, 2024–Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has received information on transactions in Zealand's shares or...
Nasdaq GlobeNewswire
19/03/2024
Changes in Group Management to continue to drive profitable growth in the ISEA…
"India and Southeast Asia is an important region for us where we have high ambitions to grow in a profitable way. Mukund's background and experience is highly relevant for our business in the ISEA region, and he will bring fresh perspectives having worked with several industries, but also with emerging markets, cleantech and start-ups," says Rickard Gustafson, President and CEO at SKF. " IndiaandSoutheast Asiais an important region for us where we have high ambitions to grow in a…
PR Newswire
19/03/2024
Abu Dhabi Global Healthcare Week and Award-winning journalist, Lara Setrakian…
Through HealthBeats, ADGHW seeks to shed light on the world's most concerning health burdens as well as delve into the trends and innovations that are shifting the tides of the global healthcare ecosystem. The series, which airs with its first episode today, will tackle some of the biggest topics set to revolutionise the healthcare industry; featuring global and local leaders, experts, and CEOs. Through HealthBeats, ADGHW seeks to shed light on the world's most concerning health burdens as...
PR Newswire
19/03/2024
Cell Expansion Market Worth $26.7 billion | MarketsandMarkets™
Browse in-depth TOC on "Cell Expansion Market" Browse in-depth TOC on "Cell Expansion Market" 514 - Tables 49 - Figures 563 - Pages Cell Expansion Market Scope: The consumables segment accounted for the largest share of the product segment in the cell expansion market in 2023. Based on products, the cell expansion market is segmented into consumables and equipment. Consumables segment dominated the market in 2023 and is expected to dominate the market in the...
PR Newswire
19/03/2024
New Supervisory Board of MAXIMA GRUPĖ and renewed Audit Committee
On 19 March, UAB Vilniaus prekyba, the sole shareholder of MAXIMA GRUPĖ, UAB, adopted a decision to reduce the number of members of the Supervisory Board from five to three, and appointed for a new term of office of four years the new Supervisory Board members Nerijus Maknevičius, Matas Kasperavičius, and Paulius Mencas. The revoked Supervisory Board included Evelina Černienė, Nerijus Maknevičius, and Jurgita Šlekytė. The composition of the Audit Committee of MAXIMA GRUPĖ, UAB was...
Nasdaq GlobeNewswire
19/03/2024
Methotrexate Drug Demand Soaring Due to Chronic Disease Burden and Biosimilar…
Demand-side Trends in The Methotrexate Drug Industry Demand-side Trends in The Methotrexate Drug Industry Download the Sample PDF report to explore key market insights and trends: https://www.futuremarketinsights.com/reports/sample/rep-gb-19288 The geriatric population, along with soaring cancer cases and autoimmune diseases across several regions, highlights the necessity of drugs like methotrexate. With weakened immune systems, older people tend to suffer from chronic...
PR Newswire
19/03/2024
Optometry Equipment Market Worth $6.1 Billion | Marketsandmarkets™
Browse in-depth TOC on "Optometry Equipment Market" Browse in-depth TOC on "Optometry Equipment Market" 321 - Tables 43 - Figures 290 - Pages Optometry Equipment Market Scope: The retina and glaucoma examination products segment hold the largest share of the optometry equipment market, by type According to product type, the worldwide optometry equipment market is divided into three segments: goods for general examinations, cornea and cataract examinations, and...
PR Newswire
19/03/2024
Digital Health in the Neurology Market worth $167.58 Bn by 2031 - Exclusive…
Digital Health In Neurology Market Report Scope: Digital Health In Neurology Market Report Scope: Request for Sample Pages:https://www.insightaceanalytic.com/request-sample/2358 Digital health in neurology refers to using eHealth and other digital tools to improve neurological disorders' diagnosis, prognosis, and treatment. Digital health technologies are on the rise in neurology due to several factors: better internet connectivity, more widespread use of smartphones, more...
PR Newswire
19/03/2024
FibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based…
About Diabetes About Diabetes Diabetes mellitus is a chronic heterogeneous metabolic disease characterized by elevated blood glucose levels due to abnormalities in either insulin production or insulin action that impacts more than 37 million people inthe United Statesand over 500 million people worldwide. Type 1 diabetes, an autoimmune disorder in which the immune system destroys the pancreatic beta cells that produce insulin, accounts for 10% of diabetes cases worldwide, and type 2...
PR Newswire
19/03/2024
Bill & Melinda Gates Medical Research Institute Initiates Phase 3 Clinical Trial…
"The launch of this pivotal Phase 3 trial demonstrates our commitment to harnessing the power of medical innovation to fight diseases like TB that are particularly devastating for low- and middle-income countries," said Emilio A. Emini, Ph.D., CEO of the Gates MRI. "Clinical study of the vaccine will still require years, but our incredible partners in South Africa and elsewhere who have come together for the Phase 3 study share our hope in the vaccine's potential." "The…
PR Newswire
19/03/2024
Moon Surgical's Maestro System powered by NVIDIA Holoscan paves the way to…
The Maestro System is used in laparoscopy, where surgeons operate through small incisions with an internal camera and instruments. The System is powered by NVIDIA Holoscan, a powerful edge computing platform that allows real-time algorithms based on Artificial Intelligence (AI) to be deployed in the operating room for immediate benefits during surgery. The Maestro System is used in laparoscopy, where surgeons operate through small incisions with an internal camera and instruments. The System…
PR Newswire
19/03/2024
Altri Comunicati